Hjem › Ikke-muskulinvasiv blærecancer
Kliniske studier for Ikke-muskulinvasiv blærecancer rekrutterer i USA
33 studier for Ikke-muskulinvasiv blærecancer rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- New York City, NY10 studier
- Columbus, OH10 studier
- Dallas, TX10 studier
- Edison, NJ9 studier
- Myrtle Beach, SC9 studier
- Syracuse, NY8 studier
- Nashville, TN8 studier
- Baltimore, MD8 studier
- Philadelphia, PA7 studier
- Birmingham, AL7 studier
- Houston, TX7 studier
- Indianapolis, IN7 studier
- Atlanta, GA7 studier
- Austin, TX6 studier
- Los Angeles, CA6 studier
- Boston, MA6 studier
- Little Rock, AR6 studier
- San Antonio, TX6 studier
- St. Louis, MO6 studier
- Chicago, IL6 studier
- Bakersfield, CA5 studier
- Memphis, TN5 studier
- Cicero, IL5 studier
- Tampa, FL5 studier
- Durham, NC5 studier
- Staten Island, NY4 studier
- Greenburgh, NY4 studier
- East Norwalk, CT4 studier
- Queens, NY4 studier
- Seattle, WA4 studier
- Jacksonville, FL4 studier
- Pittsburgh, PA4 studier
- Lakewood, CO4 studier
- Kansas City, KS4 studier
- Washington, DC4 studier
- New Rochelle, NY3 studier
- Lafayette, LA3 studier
- Cincinnati, OH3 studier
- Phoenix, AZ3 studier
- Arlington, TX3 studier
Etter delstat
- Alabama7 studier
- Arizona9 studier
- Arkansas6 studier
- California15 studier
- Colorado5 studier
- District of Columbia4 studier
- Florida15 studier
- Georgia7 studier
- Illinois11 studier
- Indiana8 studier
- Iowa3 studier
- Kansas4 studier
- Louisiana5 studier
- Maryland8 studier
- Massachusetts10 studier
- Michigan7 studier
- Minnesota4 studier
- Missouri7 studier
- New Jersey9 studier
- New York16 studier
- North Carolina6 studier
- Ohio13 studier
- Oregon3 studier
- Pennsylvania9 studier
- South Carolina12 studier
- Tennessee10 studier
- Texas15 studier
- Virginia6 studier
- Washington5 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07309445A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06733363Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT05796375A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06503614Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07144319A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT06637423Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05951179Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
RekruttererObservasjonsstudie
Alder 18 til 99 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05825950Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07480356A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
RekruttererFase 3
Alder 21 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06929286FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05614739A Phase I Intravesical PPM Therapy for NMIBC
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05519241Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT05126472Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 13. aug. 2026 · NCT07763197LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT04752722Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT07225127Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT07673016A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT05710848Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
RekruttererFase 2
Alder 18 til 99 · Alle kjønn · Oppdatert 17. apr. 2026 · NCT07322263In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. mar. 2026 · NCT06704191Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.